1000 GIST patients join global effort to unlock tumor secrets
NCT ID NCT07273045
First seen Dec 16, 2025 · Last updated May 03, 2026 · Updated 18 times
Summary
This study collects medical information and optional biological samples from 1000 people diagnosed with GIST, a rare digestive tract tumor. It does not test any new treatments or require extra visits. Researchers hope to better understand how GIST behaves, especially rare forms, and identify factors that lead to worse outcomes to help design future studies and treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIST - GASTROINTESTINAL STROMAL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Essem
Essen, North Rhine-Westphalia, 45147, Germany
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.